10x Genomics has a total of 705 patents globally, out of which 162 have been granted. Of these 705 patents, more than 75% patents are active. United States of America is where 10x Genomics has filed the maximum number of patents, followed by China and Europe. Parallelly, United States of America seems to be the main focused R&D center and is also the origin country of 10x Genomics.
10x Genomics was founded in the year 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness. Company is doing business in designing and manufacturing gene sequencing technology used in scientific research. As of December 2021, 10x Genomics has a market cap of $16.35 Billion.
Do read about some of the most popular patents of 10x Genomics which have been covered by us in this article and also you can find 10x Genomics’s patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over 10x Genomics’s patent portfolio.
How many patents does 10x Genomics have?
10x Genomics has a total of 705 patents globally. These patents belong to 187 unique patent families. Out of 705 patents, 532 patents are active.
How many 10x Genomics patents are Alive/Dead?
How Many Patents did 10x Genomics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
|Year of Patents Filing or Grant||10x Genomics Applications Filed||10x Genomics Patents Granted|
How Many Patents did 10x Genomics File in Different Countries?
Countries in which 10x Genomics Filed Patents
|United States Of America||314|
Where are Research Centers of 10x Genomics Patents Located?
10 Best 10x Genomics Patents
US20140378345A1 is the most popular patent in the 10x Genomics portfolio. It has received 337 citations so far from companies like Nugen Technologies, Cellular Research and Prognosys Biosciences.
Below is the list of 10 most cited patents of 10x Genomics:
|Publication Number||Citation Count|
Count of 102 and 103 Type Rejections based on 10x Genomics Patents
Top 10x Genomics Patents used in Rejecting Most Patent Applications
|Patent Number||Count of Rejected Applications|
What Percentage of 10x Genomics US Patent Applications were Granted?
10x Genomics (Excluding its subsidiaries) has filed 217 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 112 have been granted leading to a grant rate of 73.2%.
Below are the key stats of 10x Genomics patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for 10x Genomics?
|Law Firm||Total Application||Success Rate|
|Morgan Lewis & Bockius Llp 10X Genomics||51||78.79%|
|Clark Elbing Llp 10X Genomics Inc||30||90.00%|
|Fisherbroyles Llp 10X Genomics||7||66.67%|
|Fish & Richardson P C||4||0%|
|10X Genomics Inc||1||0.00%|
|10X Genomics Inc C O Morrison & Foerster Llp||1||0%|
|Mintz Levin 10X Genomics||1||0.00%|
|Morgan Lewis & Bockius Llp Sf||1||0.00%|
As new technologies and innovative methodologies assist and speed traditional procedures, immunology research is changing and adapting. Researchers are increasingly turning to multiomic single cell and spatial characterization technology to delve deeper into the complex molecular and cellular networks and responses of the immune system, and to translate discoveries into actionable insights for the treatment of infectious diseases, autoimmune disorders, and cancer.
10x Genomics is continuing to explore novel uses for these technologies and advance discovery in key areas of immunology research, such as:
- Vaccines and Antibody Discovery: Scientists created an unbiased, high-throughput method for screening the antibody repertoire of single B cells in order to speed up antibody discovery.
- Infectious Illness: Scientists identified epithelial–immune cellular interaction, which could lead to macrophages and neutrophils being drawn to infection-prone areas.
- Immunology’s Cellular and Molecular Mechanisms: Scientists discovered two distinct stages of innate lymphoid cell formation, as well as the molecular mechanisms that control cell fate determination.
- Immuno-oncology: Researchers discovered that immune checkpoint blockade therapy led to the recruitment of enlarged CD8+T cell clones from beyond the tumour microenvironment.
EXCLUSIVE INSIGHTS COMING SOON!
What are 10x Genomics key innovation segments?
What Technologies are Covered by 10x Genomics?
The chart below distributes patents filed by 10x Genomics in different countries on the basis of the technology protected in patents. It also represents the markets where 10x Genomics thinks it’s important to protect particular technology inventions.
R&D Focus: How 10x Genomics search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by 10x Genomics?